does glp-1 cause headaches medications and how they may change how we treat in pseudotumor cerebri patients #glp1 #pseudotumorcerebri #hydrocephalus # headaches #migraine Glucagon-like peptide-1 medicines in neurological

Patients taking GLP-1 medications often describe a reduction in what they call food noisethe persistent cravings and intrusive thoughts about eating

Contact: [email protected]

What constitutes a normal ketone pattern

In clinical medicine, microdosing GLP-1s is not a formal category

Due to their remarkable ability to regulate metabolism, they have been widely adopted in the management of type 2 diabetes mellitus (T2DM) and obesity

These effects are mediated by: Improved endothelial function and nitric oxide bioavailability Reduced vascular inflammation and oxidative stress Stabilization of atherosclerotic plaque Enhanced cardiac metabolism and mitochondrial efficiency From a longevity standpoint, microdosing may maintain low-grade GLP-1 receptor activation within vascular tissue, supporting arterial flexibility, autonomic tone, and lipid regulation without the gastrointestinal intolerance often limiting high-dose use